DIA vs JANX
DIA (DIA) versus Janux Therapeutics Inc (JANX) — a side-by-side from cached financials, not a winner call.
DIA (DIA) common stock.
Janux Therapeutics Inc (JANX) is a biotechnology company listed on US.
DIA does not have a complete income-statement cache yet.
Latest reported JANX revenue for 2026-06-30 was $10.3M. Net income was -$22.0M. JANX currently screens at market cap $1.49B.
DIA currently screens at market cap $0. JANX currently screens at market cap $1.49B.
Not investment advice. Open the DIA and JANX stock pages for the full models.
Not investment advice.